Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models. [electronic resource]
- Journal of drug targeting 12 2018
- 905-912 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1029-2330
10.1080/1061186X.2018.1450413 doi
Animals CD56 Antigen--genetics Cell Line, Tumor Chromatography, Liquid--methods Gene Expression Profiling Humans Immunoconjugates--pharmacology Lung Neoplasms--immunology Mice Oligopeptides--pharmacology Small Cell Lung Carcinoma--immunology Tandem Mass Spectrometry--methods Xenograft Model Antitumor Assays